Project Grant R01AI188431
Award Date
11/20/24
Completion Date
10/31/29
Dollars Obligated
$805K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
This Project Grant award of $1,447,376.00, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund a comprehensive investigation into the dynamics of viruses in wild bat populations. The primary objectives are to: Examine how virus shedding dynamics in bat populations and bat use of anthropogenic structures shape virus exposure risk for humans and domestic animals. Identify local- and...
This Project Grant award, totaling $734,184, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The funding supports research at Boston University Medical Campus to investigate the mechanisms of parainfluenza virus genome replication. Specifically, the project aims to: Conduct structure-guided analysis of the parainfluenza virus polymerase to identify molecular features and understand how...
This Project Grant award, valued at $792,687.00 and issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to define the structural features of sialoglycans necessary for influenza A virus (IAV) infection and adaptation across various host species. The key activities under this award include: 1) using CRISPR/Cas9 techniques to truncate different types of sialoglycans in human lung...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $123,356 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, Davis (UC Davis) to characterize the longitudinal dynamics and ecological drivers of coronavirus cross-species transmission in bat populations. The key products and services to be delivered under this grant include: 1) assessing the likelihood of coronavirus cross-species transmission in bats...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $397,135 to Colorado State University to evaluate the potential for zoonotic transmission and human infection by select simian immunodeficiency viruses (SIVs) using a humanized mouse model. The study aims to investigate the cell tropism, CD4 T cell depletion, and sexual transmission capacity of human-adapted SIV...
This Project Grant award of $755,225.00, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports the development of a unique vaccine to prevent future pandemics caused by emerging coronavirus (CoV) strains. The goal is to design a mucosal CoV vaccine that targets conserved CoV antigens (S2, M, N) to induce protective T-cell responses, particularly tissue-resident memory T cells in the upper...
This $583,047 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand how Rift Valley Fever Virus (RVFV) disseminates from the site of infection in the skin to the central nervous system (CNS). The project aims to establish the routes and mechanisms by which RVFV invades the CNS following peripheral exposure, using novel rodent CNS infection models...
This Project Grant award, valued at $681,755.00 and issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research into the intracellular assembly, maturation, and trafficking of glycoprotein complexes from four rodent-infecting hantaviruses. The research aims to delineate the virus-host interactions required for the proper localization and function of these glycoprotein complexes, which...
This Project Grant award of $197,366 from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 - Allergy and Infectious Diseases Research program supports research to understand the mechanisms by which the human immune system naturally restricts a specific subset of HIV known as X4-tropic virus. The 5-year research study, commencing on March 1, 2025, aims to characterize the molecular mechanisms that drive the restriction of X4-tropic viral replication in the...
This $477,226 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to discover novel antiviral systems in microbial eukaryotes. The research will focus on understanding how the amoeba genus Acanthamoeba defends against giant viruses called Megavirales, and then expand that knowledge to other microbial eukaryotes. The project will leverage cutting-edge AI techniques and...